News and Views

Work from the Andersen lab and colleagues is the first to show that Ebola virus can gain mutations that change its function.

The findings from the Sherman lab suggest a new drug target for cancer, chronic infections.

Using nucleophilic probes, researchers from the Cravatt lab discover a novel electrophilic protein modification.

Professor Ian Wilson shares his insights.

Team Uncovers Why Hepatitis C Virus Vaccine Has Been Difficult to Make
Researchers Illuminate Key Molecular Player in Both Morphine Addiction and Rare Disease
TSRI and Calibr Sign Strategic Affiliation to Accelerate the Development of New Medicines
International Team Unveils First Atomic-Level Image of the Human 'Marijuana Receptor'
Scientists Uncover New Facets of Zika-Related Birth Defects to Help Develop Treatment
Decoding Emotions and the Brain: A Profile of Lisa Stowers
Scientists Use ‘Molecular Autopsies’ to Find Clues to Sudden Death
Grant to TSRI-Led Consortium Expands to $207 Million
TSRI Celebrates 20th Anniversary of Transformative Skaggs Family Gift
News from the Primordial World
Findings Illuminate How Mystery MS Drug Works
Study Suggests Repurposed Deworming Drugs Could Combat C. Difficile Epidemic
Team Discovers Antibodies that Target Holes in HIV's Defenses
Team Harnesses Antibody Evolution on the Path to an AIDS Vaccine